Evaluation of orally administered salbutamol in the relief of bronchospasm in bronchial asthma.
D000284:Administration, Oral; D000328:Adult; D000403:Airway Resistance; D000420:Albuterol / Q000008:administration & dosage* / Q000627:therapeutic use; D001249:Asthma / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D001986:Bronchial Spasm / Q000150:complications / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007545:Isoproterenol / Q000009:adverse effects / Q000627:therapeutic use; D008170:Lung Compliance; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011653:Pulmonary Diffusing Capacity; D012123:Pulmonary Ventilation; D013997:Time Factors; D014797:Vital Capacity
D010919:Placebos; D007545:Isoproterenol; D000420:Albuterol